Innovative solutions to the greatest challenges in pharmaceutical development

11th – 13th March 2019 | Berlin


The perfect mix.
The DDF Summit brings together leading formulation development, drug delivery and device development professionals from both industry and academia to share and discuss their latest work.


Quality content. The agenda is packed with carefully selected talks on topics as diverse as the challenges you face.

Invaluable networking. The DDF community is open, friendly and represents and incredibly valuable network of scientists working at the forefront of their field. There is ample networking time built in to help you make and strengthen connections.

Tailor your experience. 4 parallel streams give you the chance to personalise your agenda and delve deep into the topics pertinent to your challenges. Choose from Small Molecules, Biologics, Technology & Innovation or Device Development.

The right size. This year the DDF Summit will be limited to just 500 people, in order to maintain the quality of the networking and comfort for participants. This means that there will only be 250 delegate tickets available. So, don’t waste time in getting yours.

Key themes for 2019 include:

  • Analytical techniques for biotherapeutics
  • mAb and bispecific formulation development
  • Oral delivery of biologics and other routes
  • Device development and next generation biotherapeutics
  • Nanoparticle formulations
  • Continuous manufacturing
  • Integrating human factors into device development

Have a look at the full agenda here.

Download 2019 Brochure

Speakers

Advait Badkar

Pfizer

Senior Director

Alan S Harris

Ferring

Senior VP, Global R&D Life Cycle Management

Alessandro Fioni

Chiesi

DMPK Senior Scientist

Anacelia Ríos Quiroz

Roche

Scientist - Group Leader Particle Lab Biologics

Anand Subramony

MedImmune

Vice President Novel Product Technologies

Andreas Seidl

Novartis

Head Global Analytical Characterization & Bioanalytics

Anette Müllertz

University of Copenhagen

Professor, Head of Center

April Kent

Amgen

Regulatory Affairs Manager, Devices; Device Lead for AMG 162, IVD Lead for AMG 701 + 596

Beat Steffen

Confinis

Founder and Chief Executive Officer

Ben Van Hove

Janssen

Associate Director Drug Product Development, Oral Solid Dosage Forms

Birger Brodin

University of Copenhagen

Faculty of Health and Medical Sciences Department of Pharmacy CNS Drug Delivery and Barrier Modelling

Christer Tannergren

AstraZeneca

Associate Principal Scientist in Biopharmaceutics

Corinna Sonderegger

Novartis

Head Portfolio Management Device Development & Commercialization

Daniel Latham

Novartis

Head – Device Development & LCM Device Development & Commercialisation

Dr. Carsten Timpe

Roche

Expert Scientist

Dr. Elisabeth Kersten

Bayer

Lab Head Early Formulation Development

Dr. Martin Hüelsmeyer

AbbVie

Head of HTS Operations & Analytics NBE Formulation Sciences, Principal Research Scientist

Dr. Matthias G. Wacker

Fraunhofer-Institute for Molecular Biology and Applied Ecology

Head of Department, Pharmaceutical Technology and Nanosciences

Dr. Yogeshwar Bachhav

AiCuris Anti-infective Cures

Associate Director Pharmaceutical Development

Gerhard Wenz

Saarland University

Professor

Harivardhan-Reddy Lakkireddy

Sanofi

Head of Drug Delivery Technologies & Innovation - Nanotechnologies

Heloise Audat

Sanofi

Head of Late Stage Formulation Development Unit, Biologics

Jacqueline Maximilien

Janssen 

Senior Scientist

James Meehan

AstraZeneca

Associate Principal Scientist – Human Factors

Jesper Lau

Novo Nordisk

Vice President, Protein and Peptide Chemistry

Johannes Khinast

Research Center Pharmaceutical Engineering

Director

Kerstin Walke

Boehringer Ingelheim

Head of Pharmaceutical Development Biologicals

Marc Du Jardin

Janssen

Associate Director

Marc-Antoine Fabre

Sanofi

Global Head Biopharmacy

Mario Maio

Polyphor

Head CMC Development

Mark R.H. Krebs

Janssen

Head of Formulation Development

Michael Siedler

AbbVie

Head of NBE Formulation Development - NBE Formulation Sciences & Process Development

Mostafa Nakach

Sanofi

Head of Pharmaceutical Engineering

Olaf Queckenberg

Bayer

Head of Chemical & Pharmaceutical Development

Patrick Garidel

Boehringer Ingelheim

Associate Director Protein Science

Prof. Dr. Robert Luxenhofer

Wuerzburg University

Chair of Chemical Technology of Materials Synthesis

Prof Rainer Jordan

TU Dresden

Professor of Macromolecular Chemistry

Rémy Vomscheid

Ipsen

Director, Device Development & Technologies

Sabine Eichling

AbbVie

Senior Scientist II, NBE High Throughput and Advanced Formulation Sciences Drug Product Development

Sachin Dubey

Glenmark

Head of Formulation and Analytical Development

Samuel Kyeremateng

Abbvie

NCE Formulation Sciences Senior Scientist

Satya Krishna Kishore Ravuri

Roche

Senior Group Leader, Early-Stage Pharmaceutical and Processing Development

Simon Bjerregaard

Ferring

Senior Research Scientist

Stephanie Greco

Sanofi

Head of laboratory in Pharmaceutical Engineering

Stephen Buckley

Novo Nordisk

Head of the Discovery ADME Department in Global Research

Sune Andersen

Janssen

Principal Scientist Spray Drying

Sven Stegemann

Lonza

Director, Pharmaceutical Business Development

Thomas Hoeg-Jensen

Novo Nordisk

Scientific Director

Tim Rouse

Chiesi

Senior Scientist

Tina Bjeldskov Pedersen

Novo Nordisk

Head of Department Oral Formulation Research

Graham B Jones

Novartis

Director of Innovation

Rajeev Gokhale

Roquette

Head Global Pharmaceutical Sciences R&D, Head Asia R&D

Louise Place

Cambridge Design Partnership

Head Of Regulatory Affairs and Senior Quality Assurance Consultant

X

Download the 2019 Brochure

Download 2019 Brochure